Zhi-Yong Wu
Overview
Explore the profile of Zhi-Yong Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
244
Citations
2231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Y, Shi Z, Zhu T, Zhou T, Li Y, Li W, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2413702.
PMID: 39921294
Accurately predicting pathological complete response (pCR) to neoadjuvant treatment (NAT) in breast cancer remains challenging due to tumor heterogeneity. This study enrolled 2279 patients across 12 centers and develops a...
2.
Qiu S, He X, Liang X, Shi G, Zhao M, Li F, et al.
Eur J Nucl Med Mol Imaging
. 2025 Jan;
PMID: 39833507
Purpose: Precise tumor excision is important but challenging in breast-conserving surgery (BCS). Tumor-specific fluorescence imaging may be used for intraoperative tumor detection and, therefore, to guide precise tumor excision. The...
3.
Qiu Z, Xie L, Li Y, Zhang Z, Chen H, Zhan W, et al.
Breast Cancer Res Treat
. 2025 Jan;
PMID: 39832050
Purpose: Precise tumor excision is important in breast-conserving surgery (BCS). This study explores the safety and accuracy of fluorescence image-guided BCS (FIGS) using a lidocaine mucilage-ICG compound (L-ICG). Methods: 54...
4.
Han D, Chen Y, Zhao K, Li H, Chen X, Zhu G, et al.
Arch Biochem Biophys
. 2024 Nov;
762:110215.
PMID: 39547552
Skeletal muscle atrophy, characterized by loss of muscle mass and function, is often linked to systemic inflammation. Tanshinone IIA (Tan IIA), a major active constituent of Salvia miltiorrhiza, has anti-inflammatory...
5.
Shi W, Chen D, Du Z, Liu C, Zhai T, Pan F, et al.
Cancer Cell Int
. 2024 Oct;
24(1):340.
PMID: 39402601
Background: Immune checkpoint blockade (ICB) has been improving the patient outcome in multiple cancer types. However, not all patients respond to ICB. Biomarkers are needed for selecting appropriate patients to...
6.
Yu Y, Li X, Bu F, Zhao Z, Wu Z, Li Y
Mol Pharm
. 2024 Oct;
21(11):5716-5727.
PMID: 39392428
An integrated strategy by combining cocrystallization with nanotechnology is developed to optimize in vitro/vivo performances of marine antitumor drug cytarabine (ARA) and further obtain innovative insights into the exploitation of...
7.
Cheng C, Sun W, Wu Z, Cao X, Liu C, Zhang Y
Aesthetic Plast Surg
. 2024 Sep;
48(24):5373-5380.
PMID: 39322842
Background: Although current penile enlargement techniques can improve appearance, it remains unclear whether these procedures increase sexual function. We aimed to systematically compare the surgical outcomes, with a particular focus...
8.
Zhu T, Huang Y, Li W, Wu C, Zhang Y, Zheng X, et al.
Br J Cancer
. 2024 Jun;
131(4):692-701.
PMID: 38918556
Background: This study aims to develop a stacking model for accurately predicting axillary lymph node (ALN) response to neoadjuvant chemotherapy (NAC) using longitudinal MRI in breast cancer. Methods: We included...
9.
Bu F, Meng S, Wang L, Wu Z, Li Y
Spectrochim Acta A Mol Biomol Spectrosc
. 2024 May;
317:124403.
PMID: 38710138
In order to make novel breakthroughs in molecular salt studies of BCS class-IV antifungal medication bifonazole (BIF), a salification-driven strategy towards ameliorating attributes and aiding augment efficiency is raised. This...
10.
Li W, Huang Y, Zhu T, Zhang Y, Zheng X, Zhang T, et al.
Ann Surg
. 2024 Apr;
281(4):645-654.
PMID: 38557792
Objective: To develop an artificial intelligence (AI) system for the early prediction of residual cancer burden (RCB) scores during neoadjuvant chemotherapy (NAC) in breast cancer. Background: RCB III indicates drug...